The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients
Clinical trial NCT01137799 · TERMINATED
Trial details
- NCT number
- NCT01137799
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.